Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 264 studies with search of: | "Sunitinib" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Not yet recruiting |
Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
|
||||
2 | Active, not recruiting |
A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies
|
||||
3 | Active, not recruiting |
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
|
||||
4 | Recruiting |
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
|
||||
5 | Recruiting |
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
|
||||
6 | Recruiting |
SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme
|
||||
7 | Active, not recruiting |
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
|
||||
8 | Not yet recruiting |
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
|
||||
9 | Recruiting |
Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy
|
||||
10 | Recruiting |
Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer
|
||||
11 | Active, not recruiting |
Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
|
||||
12 | Recruiting |
Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
|
||||
13 | Recruiting |
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
|
||||
14 | Recruiting |
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
|
||||
15 | Recruiting |
Randomized Phase II Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced RCC
|
||||
16 | Recruiting |
Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
|
||||
17 | Completed |
A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together
|
||||
18 | Active, not recruiting |
Ph I SU011248 + Irinotecan in Treatment of Pts w MG
|
||||
19 | Recruiting |
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
|
||||
20 | Active, not recruiting |
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |